In conclusion, our epigenomic, transcriptomic and proteomic results implicate NHR signalling in CE, shedding new light on its pathogenic mechanism and paving the way for exploring NHR-PCDH19 regulated pathways as future potential therapeutic options. This evidence concerns the gene PCDH19 and cholesteryl ester measurement.